Search Results - endometrial+cancer

4 Results Sort By:
STING Agonist 8803 for Blood-Brain Barrier Opening in Glioblastoma Treatment
SHORT DESCRIPTION Chemical compound that opens the blood-brain barrier to enhance delivery of therapeutics for treating glioblastoma. INVENTORS Amy Heimberger* Northwestern University Feinberg School of Medicine, Department of Neurological Surgery * Principal Investigator NU Tech ID: NU 2025-212 IP...
Published: 5/7/2026   |   Updated: 4/27/2026   |   Inventor(s):  
Keywords(s): AD - Alzheimer’s Disease, Adjunct therapy, ALS - Amyotrophic Lateral Sclerosis, Animal Model, Autoimmune disease, Bladder cancer, Brain cancer, Breast cancer, Cancer Treatment, Cancer/Oncology, Cervical cancer, CNS - Central Nervous System, Colon cancer, Drug delivery, Endometrial cancer, Gastric cancer, GBM - Glioblastoma, Head and neck cancer, Immunology, Immunotherapy, Liver cancer, Lung cancer, MS - Multiple Sclerosis, Neurodegenerative disease, Neurologic disease, Ovarian cancer, Pancreatic cancer, PD - Parkinson's Disease, Prostate cancer, Repurposed Drugs, Research tool, Small molecule, Targeted therapy, TBI - Traumatic brain injury, Therapeutics
Category(s): Life Sciences > Therapeutics, Life Sciences > Biomarkers & Biomedical Research Tools
NU-CATS risk score for endometrial cancer prognosis
NU 2023-107 INVENTORS Shuhua Zheng* Eric Donnelly Jonathan Strauss SHORT DESCRIPTION Machine learning-based new unified risk classification score (NU- CATs) for patients with endometrial cancer. BACKGROUND Clinically relevant classification of endometrial cancer is important for prognosis and predictions of treatment success. Traditionally,...
Published: 2/6/2026   |   Updated: 7/10/2024   |   Inventor(s):  
Keywords(s): Artificial Intelligence & Machine Learning, AUTM26_1, Cancer/Oncology, Diagnostics, Endometrial cancer
Category(s): Life Sciences > Healthcare Devices, Tools & IT, Physical Sciences > Software & Services
Mutants Having a Deficit of Functional Steroid Hormone Receptors
This invention concerns "knockout" animals, including mice, which have a deficit of functional steroid hormone receptors, DNA constructs containing the mutations, and methods for producing the animals. The mutation is introduced into the animal or its ancestors at an embryonic stage. These knockout animals provide a model system for studying the biological...
Published: 10/28/2024   |   Updated: 12/6/2022   |   Inventor(s): Kenneth Korach
Keywords(s): BAXXXX, Endometrial cancer, ICXXXX, IXXXXX
Category(s): Collaboration Sought > Licensing, Application > Diagnostics, ResearchProducts > Animal Models, Application > Research Materials, Application > Therapeutics
IDO-PROTACs for Improving the Anti-Cancer Immune Response
NU 2020-137 INVENTORS Derek Wainwright* Gary Schiltz SHORT DESCRIPTION IDO-PROTAC that target immunosuppressive IDO activity via degradation ABSTRACT The median survival of primary GBM patients following aggressive surgical intervention, radiotherapy, chemotherapy, and tumor treating fields (TTF) is only ~14-16 months. Indoleamine 2,3-dioxygenase...
Published: 5/6/2026   |   Updated: 5/27/2022   |   Inventor(s):  
Keywords(s): AUTM26C1, BIAUTM1, Brain cancer, Cancer/Oncology, Colon cancer, Endometrial cancer, Immunotherapy, Pancreatic cancer, Prostate cancer, PROTAC, Small molecule, Targeted protein degradation, Targeted therapy, Therapeutics
Category(s): Life Sciences > Therapeutics